InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Browse the full record of transactions filed by COLLIS STEVEN H, Executive Chairman of the Board. Officer active across 2 companies, notably Amerisourcebergen CORP. In total, 44 filings have been published. Total volume traded: €10.1m. The latest transaction was filed on 13 May 2026 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations44 total
0563 shares0
Common Stock
SEC:0001191508-26-000004·
0563 shares0
Common Stock
SEC:0001191508-26-000004:0·
€831,37311,480 shares@ €72.41931.8% of flow
Common Stock
SEC:0001127602-22-017621:0·
€824,08211,480 shares@ €71.78411.8% of flow
Common Stock
SEC:0001127602-22-014278:0·
€801,76611,480 shares@ €69.84021.7% of flow
Common Stock
SEC:0001127602-22-011945:0·
€798,87511,480 shares@ €69.58841.7% of flow
Common Stock
SEC:0001127602-22-008793:0·
€1m12,783 shares@ €85.85192.4% of flow
Common Stock
SEC:0001127602-22-003966:0·
€1m12,783 shares@ €85.85195.1% of flow
Common Stock
SEC:0001127602-22-003966·
€1m12,784 shares@ €86.70475.2% of flow
Common Stock
SEC:0001127602-22-001450·
€1m12,784 shares@ €86.70472.4% of flow
Common Stock
SEC:0001127602-22-001450:0·
01,159 shares0
Common Stock
SEC:0001127602-22-000099·
01,159 shares0
Common Stock
SEC:0001127602-22-000099:0·
€2m17,168 shares@ €109.62368.8% of flow
Common Stock
SEC:0001127602-21-031105·
€2m17,168 shares@ €109.62364.1% of flow
Common Stock
SEC:0001127602-21-031105:0·
€1m12,784 shares@ €87.05055.2% of flow
Common Stock
SEC:0001127602-21-030978·
€1m12,784 shares@ €87.05052.4% of flow
Common Stock
SEC:0001127602-21-030978:0·
€2m17,168 shares@ €109.96968.8% of flow
Common Stock
SEC:0001127602-21-029777·
€2m17,168 shares@ €109.96964.1% of flow
Common Stock
SEC:0001127602-21-029777:0·
€1m11,664 shares@ €109.67346.0% of flow
Common Stock
SEC:0001127602-21-029538·
€1m11,664 shares@ €109.67342.8% of flow
Common Stock
SEC:0001127602-21-029538:0·
89,306 shares
Common Stock
SEC:0001127602-21-029256·
89,306 shares
Common Stock
SEC:0001127602-21-029256:0·
€1m12,784 shares@ €84.75165.1% of flow
Common Stock
SEC:0001127602-21-028992·
€1m12,784 shares@ €84.75162.4% of flow
Common Stock
SEC:0001127602-21-028992:0·
€1m12,784 shares@ €85.17415.1% of flow
Common Stock
SEC:0001127602-21-027080·
25 of 44 declarations
About COLLIS STEVEN H
Steven H. Collis is a U.S. healthcare and distribution executive best known for his long career at Cencora, formerly AmerisourceBergen. He joined the company in 1994 and held a series of senior leadership roles across major pharmaceutical distribution and specialty services businesses. In 2011, he was appointed President and Chief Executive Officer after previously serving in operational leadership roles, including President and Chief Operating Officer. He later served as Chairman of the Board and became Executive Chairman in 2024. His tenure was characterized by a strong focus on operational execution, the resilience of pharmaceutical supply chains, and the continued expansion of the company’s North American and global footprint. Under his leadership, the company also completed its rebranding from AmerisourceBergen to Cencora in 2023, a move intended to better reflect its broader international identity and strategic scope. In addition to his Cencora responsibilities, Collis joined the board of Elevance Health, underscoring his reputation as an experienced governance leader with deep knowledge of healthcare, regulated distribution, and long-term value creation. His profile also reflects involvement with healthcare-related organizations and public-company board service, reinforcing his standing as a seasoned executive with a governance-oriented and performance-driven leadership style.
